By vgreene, 5 February, 2021 May use FeNO as part of monitoring w hx clinical findings spirometry in pts w persistent allergic asthma
By vgreene, 5 February, 2021 F U q2 6wk to achieve control then q1 6mo to monitor control q3mo if step down tx anticipated
By vgreene, 5 February, 2021 If persistent allergic asthma consider SC immuno tx strongest evidence for single allergen tx evidence weak lacking for mold cockroach
By vgreene, 5 February, 2021 If alternative tx used switch to preferred tx for current step If side effects consider alternative tx
